(Q43000025)

English

Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

scientific article published in May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms (English)

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

0 references

Michael P. Busch

5

object named as

Michael P Busch

1 reference

Europe PubMed Central

12 November 2017

Susan L Stramer

2

object named as

Susan L Stramer

1 reference

Europe PubMed Central

12 November 2017

4

object named as

Sally Caglioti

1 reference

Europe PubMed Central

12 November 2017

3

object named as

Jaye P Brodsky

1 reference

Europe PubMed Central

12 November 2017

author name string

Steven H Kleinman

1

1 reference

Europe PubMed Central

12 November 2017

publication date

1 May 2006

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

46

1 reference

Europe PubMed Central

12 November 2017

5

1 reference

Europe PubMed Central

12 November 2017

695-702

1 reference

Europe PubMed Central

12 November 2017

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Clearance of hepatitis C virus after newly acquired infection in injection drug users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Prediction of relapse following treatment for hepatitis C: is whole blood more than the sum of its parts?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Indeterminate results in blood donor testing: what you don't know can hurt you.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

The donor notification process from the donor's perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood‐donor screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Complete or partial seroreversion in immunocompetent individuals after self-limited HCV infection: consequences for transfusion.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00787.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2006.00787.X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43000025&oldid=1976331229"